关注
Pratish C Patel
Pratish C Patel
Vanderbilt University Medical Center
在 vumc.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
The Emperor’s New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With …
TP Lodise Jr, SL Rosenkranz, M Finnemeyer, S Evans, M Sims, ...
Clinical Infectious Diseases 70 (8), 1536-1545, 2020
1452020
From natural disaster to pandemic: A health-system pharmacy rises to the challenge
AD Zuckerman, PC Patel, M Sullivan, A Potts, M Knostman, E Humphreys, ...
American Journal of Health-System Pharmacy, 2020
322020
Therapeutic drug monitoring of piperacillin and tazobactam by RP-HPLC of residual blood specimens
SM Verhoven, JJ Groszek, WH Fissell, A Seegmiller, J Colby, P Patel, ...
Clinica Chimica Acta 482, 60-64, 2018
272018
Commonly used fluoroquinolones cross-react with urine drug screens for opiates, buprenorphine, and amphetamines
JM Colby, PC Patel, DY Fu, NJ Rutherford
Clinical biochemistry 68, 50-54, 2019
182019
The emperor’s new clothes: prospective observational evaluation of the association between the day 2 vancomycin exposure and failure rates among adult hospitalized patients …
TP Lodise Jr, SL Rosenkranz, M Finnemeyer, J Huvane, A Pereira, ...
Open Forum Infectious Diseases 4 (suppl_1), S30-S31, 2017
122017
External Validation and Comparison of Clostridioides difficile Severity Scoring Systems
DA Perry, D Shirley, D Micic, PC Patel, R Putler, A Menon, VB Young, ...
Clinical Infectious Diseases, 2021
112021
Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment Analysis
G An, CB Creech, N Wu, RL Nation, K Gu, D Nalbant, N Jimenez-Truque, ...
Antimicrobial Agents and Chemotherapy, e01312-22, 2023
82023
Lenacapavir (Sunlenca®) for the treatment of HIV-1
PC Patel, HK Beasley, A Hinton, CN Wanjalla
Trends in Pharmacological Sciences 44 (8), 553-554, 2023
72023
Beta-lactam carryover in arterial and central venous catheters is negligible
E Marsh, SM Verhoven, JJ Groszek, WH Fissell, G An, P Patel, B Creech, ...
Clinica Chimica Acta 486, 265-268, 2018
52018
Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients
G An, CB Creech, N Wu, RL Nation, K Gu, D Nalbant, N Jimenez-Truque, ...
Journal of antimicrobial chemotherapy 78 (6), 1460-1470, 2023
22023
Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients with Cystic Fibrosis
SL Rolsma, A Sokolow, PC Patel, K Sokolow, N Jimenez-Truque, ...
The Journal of Infectious Diseases, jiae451, 2024
2024
1859. Median Income by Location of Residence and Clinical Outcomes of Hospitalized Persons with COVID-19 in an Urban Veterans Affairs Medical Center
M Tuck, H Rivasplata, S Towers, AP Liappis, C Arundel, A Dinescu, ...
Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 1687, 2023
2023
1472. Development of an Interactive Provider Dashboard for Enhanced Recovery After Surgery to Monitor Compliance with Perioperative Surgical Site Infection Measures
PC Patel, BL Raymond, B Cherry, J Jayaram, MD McEvoy
Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 1308, 2023
2023
Are We Dosing Correctly? Population Pharmacokinetic Modeling of Cefepime, Piperacillin-Tazobactam, and Meropenem in Individuals with Cystic Fibrosis
SL Rolsma, AG Sokolow, G An, N Fishbane, W Fissell, K Gu, N Jimenez, ...
Journal of the Pediatric Infectious Diseases Society 12 (Supplement_1), S8-S8, 2023
2023
597. Are We Dosing Correctly? Population Pharmacokinetic Modeling of Cefepime, Piperacillin-Tazobactam, and Meropenem in Individuals with Cystic Fibrosis
SL Rolsma, G An, N Fishbane, W Fissell, K Gu, N Jimenez, C Kirkpatrick, ...
Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 649, 2022
2022
537. Implementation of a Workflow for COVID-19 Monoclonal Antibody Infusions at a Veterans Affairs Medical Center
PC Patel, A Adenew, A McKnight, K Jeng, AP Liappis
Open Forum Infectious Diseases 8 (Supplement_1), S370-S370, 2021
2021
250. An Assessment of the Penicillin Allergy Label in Patients Undergoing Orthopedic Procedures at a VA Medical Center
S Meledathu, MK Firek, AP Liappis, PC Patel
Open Forum Infectious Diseases 8 (Suppl 1), S232, 2021
2021
2409. External Validation and Comparison of Clostridioides difficile Severity Scoring Systems
DA Perry, D Shirley, D Micic, RKB Putler, P Patel, A Menon, P Higgins, ...
Open Forum Infectious Diseases 6 (Supplement_2), S831-S832, 2019
2019
Clinical Characteristics of S. aureus Bloodstream Infections in Children
G Fricker, M Jameson, P Patel, B Creech
Journal of the Pediatric Infectious Diseases Society 7, 2018
2018
Treatment Outcomes of Clostridium difficile Infection in Neutropenic Adults
M Kenes, P Patel, W Jones, G Nelson, J Stollings, M Marshall, D Aronoff
Open Forum Infectious Diseases 2 (suppl_1), 1018, 2015
2015
系统目前无法执行此操作,请稍后再试。
文章 1–20